Developing injectable stem cell therapies for the treatment of perianal fistulas.
Industry: Health Care
First Day Return: -24.5%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 12/22/2015 |
Offer Price | $15.50 |
Price Range $15.50 - $15.50 | |
Offer Shares (mm) | 2.3 |
Deal Size ($mm) | $36 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 12/14/2016 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $36 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Leuven, Belgium |
Founded | 2000 |
Employees at IPO | 74 |
Website www.tigenix.com |